| 产品名称： | Human Coxsackievirus A 21 |
|---|---|
| 商品货号： | TS158625 |
| Classification： | Picornaviridae, Enterovirus, Human enterovirus C |
| Deposited As： | coxsackievirus A21 |
| Agent： | Human Coxsackievirus A 21 |
| Strain： | Kuykendall V-024-001-012 |
| Applications： | Respiratory research |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | Stool from 17 yr. old male with paralytic illness, California, 1952 |
| Product Format： | frozen |
| Storage Conditions： | -70°C or colder |
| Comments： | Derived from NIAID V-024-001-012. A21 may be a natural recombinant between poliovirus and rhinovirus (Shafren et al J. Virol 71:4736,1997; Hughes et al, J.Gen Virol 70:2943,1989) Identical to Coe virus. (Schmidt, NJ et al., Proc. Soc. Exp. Biol. Med. 107: 63, 1961>) Complete destruction of cell sheet in HAm cell cultures occurs within 3 days. A21 is associated with human upper respiratory infections. |
| Effect on Host： | Yes, in vitro effects: Cytopathic effects in tissue culture CPE, cell rounding and sloughing |
| Recommended Host： | human amnion cells Recommended Host: WISH cells (ATCC® CCL-25x99) human amnion cells in tissue culture |
| Growth Conditions： | Duration: 2-3 days |
| Name of Depositor： | NIH/NIAID |
| Source： | Stool from 17 yr. old male with paralytic illness, California, 1952 |
| Year of Origin： | 1952 |
| References： | Sickles GM, et al. New types of Coxsackie virus, group A. Cytopathogenicity in tissue culture. Proc. Soc. Exp. Biol. Med. 102: 742-743, 1959. PubMed: 14446401 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Human Coxsackievirus A 21 |
|---|---|
| 商品货号： | TS158625 |
| Classification： | Picornaviridae, Enterovirus, Human enterovirus C |
| Deposited As： | coxsackievirus A21 |
| Agent： | Human Coxsackievirus A 21 |
| Strain： | Kuykendall V-024-001-012 |
| Applications： | Respiratory research |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | Stool from 17 yr. old male with paralytic illness, California, 1952 |
| Product Format： | frozen |
| Storage Conditions： | -70°C or colder |
| Comments： | Derived from NIAID V-024-001-012. A21 may be a natural recombinant between poliovirus and rhinovirus (Shafren et al J. Virol 71:4736,1997; Hughes et al, J.Gen Virol 70:2943,1989) Identical to Coe virus. (Schmidt, NJ et al., Proc. Soc. Exp. Biol. Med. 107: 63, 1961>) Complete destruction of cell sheet in HAm cell cultures occurs within 3 days. A21 is associated with human upper respiratory infections. |
| Effect on Host： | Yes, in vitro effects: Cytopathic effects in tissue culture CPE, cell rounding and sloughing |
| Recommended Host： | human amnion cells Recommended Host: WISH cells (ATCC® CCL-25x99) human amnion cells in tissue culture |
| Growth Conditions： | Duration: 2-3 days |
| Name of Depositor： | NIH/NIAID |
| Source： | Stool from 17 yr. old male with paralytic illness, California, 1952 |
| Year of Origin： | 1952 |
| References： | Sickles GM, et al. New types of Coxsackie virus, group A. Cytopathogenicity in tissue culture. Proc. Soc. Exp. Biol. Med. 102: 742-743, 1959. PubMed: 14446401 |
